British scientists have developed what they are describing as a “Trojan horse” technique for targeting hard-to-reach cancers and degenerative diseases.
The technique, developed by scientists at Brunel University London, uses tiny nanoparticles and does not cause the damaging side effects that can accompany chemotherapy, radiation, and other conventional treatments.
In a huge step forward in the use of nanomedicine, the research discovered proteins in the blood that can be used to disguise nanoparticles so they are absorbed into tumor cells in brain cancer — without causing inflammation or destroying healthy cells.
"By using a protein recognized by the immune system to effectively disguise carbon nanoparticles, we will be able to deploy these tiny particles to target hard-to- reach areas without damaging side effects to the patient,” said Uday Kishore, M.D.
“This is a big step forward. It is like understanding how to use penicillin safely and could be as revolutionary to modern medicine as its 20th century predecessor."
© 2026 NewsmaxHealth. All rights reserved.